Prenetics Global PRE
NASDAQ PRE
$24.19 +0.00 (+0.00%)
At close: Sep 18, 2026 · 4:00 PM EDT

Prenetics Global (PRE) Short term Debt (2022 - 2023)

Prenetics Global's (PRE) quarterly Short term Debt came in at $4.2 million in Q4 2023, little changed year-over-year from $4.2 million in Q4 2022, and little changed quarter-over-quarter from $4.2 million in Q4 2022.

Analysis

Prenetics Global (PRE) Short term Debt (2022 - 2023) Analysis & Trends

Prenetics Global (PRE) has reported Short term Debt for 2 consecutive years, with $4.2 million the latest figure, recorded in Q4 2023.

  • On a quarterly basis, Short term Debt changed 0.15% year-over-year to $4.2 million in Q4 2023; TTM through Dec 2023 was $4.2 million, a 0.15% change from a year earlier, with the FY2023 full-year figure at $4.2 million, changed 0.15% from the prior year.
  • Short term Debt was $4.2 million for Q4 2023 at Prenetics Global, roughly flat from $4.2 million in the prior quarter.
  • Over five years, Short term Debt peaked at $12.1 million in Q1 2022 and troughed at $4.2 million in Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 GE HealthCare Technologies 28.97 Bn 27.09 Bn 2.18 Bn
2 Lantheus Holdings 6.56 Bn 5.97 Bn 241.86 Mn
3 Heartflow 4.40 Bn 4.03 Bn 53.19 Mn
4 Neogen 2.83 Bn 2.64 Bn 107.80 Mn
5 Butterfly Network 1.88 Bn 1.75 Bn 23.29 Mn
6 Ceribell 931.50 Mn 802.24 Mn 25.94 Mn
7 Varex Imaging 779.32 Mn 694.02 Mn 76.70 Mn
8 Anbio Biotechnology 755.43 Mn 743.53 Mn -
9 QuidelOrtho 725.35 Mn 601.95 Mn -
10 Prenetics Global 339.92 Mn 280.78 Mn 30.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 4.25 Mn
Dec 31, 2022 4.24 Mn
Jun 30, 2022 9.20 Mn
Mar 31, 2022 12.08 Mn